Europe Automated Compounding Systems Market Key Companies and SWOT Analysis by 2027

The Europe automated compounding systems market is expected to reach US$ 182.88 million by 2027 from US$ 111.28 million in 2019. The market is estimated to grow with a CAGR of 6.6% from 2020 to 2027.

The growth of the market is driven by factors such as the growing adoption of chemotherapy and personalized medication and rising need to minimize medication errorsin the Europe region. However, high cost and reluctance to adopt the automated compounding systems and COVID-19 pandemicis likely to restrain the market growth to a certain extent.

Automated compounding system is a device that combines one or more drug solutions to final container for patient administration. Automated compounding system helps avoid medication error that occurs due to variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion that was arising out of the use of similar labels. However, with the automated compounding systems, the accuracy as well as efficiency of dispensing compounded products have improved, and it has further reduced the exposure of healthcare professionals to toxic agents.

Several manufacturers are developing robotics automating compounding systems. For instance, the robotic arms of Kiro Oncology® (Grifols) perform separate tasks simultaneously, the movement of disposable items are minimized in the compounding area and the decontamination of hazardous chemicals is realized by self-cleaning. Kiro Oncology® is classified as a class II A2 biosafety cabinet and the compounding are is ISO 5 classified. For instance, the intelligent compounding system (= ICS®, Steriline) is a fully automated robotic solution, based on isolator technology, controlled by software, which compounds parenteral medication doses into the appropriate final containers within a controlled environment (ISO class 4.8, grade A). It includes a bio-decontamination system with vaporized H2O2 sterilization technology; therefore, it can be installed in an ISO class 8 (grade D) background environment. The ICS® can handle both hazardous and non-hazardous medications and both patient specific and batch production. The ICS includes state of the art automation and robotics to perform the following tasks without requiring human intervention. Therefore, innovative technology of robotics automation in compounding systems is a major factor for the market growth.

The rapid adoption of novel therapies, such as chemotherapy in oncology has been reported to provide better treatment options for breast, lung, and prostate cancers. Similarly, the area of precision and personalized medicine (PPM) is developed to make therapies for a single patient or specific groups based on data that captures current and past physical health and environmental experience. Recently, several reports show that the assimilation of PPM viewpoint into cancer research and treatment will result into significant enhancements in fighting cancer, mainly due to its complexity and interpatient unpredictability.

Several manufactures offer automated compounding systems toward chemotherapy and personalized medicines. For instance, Pharmoduct (Comecer) is an automated device used for the sterilized preparation of personalized oncology drugs, which includes chemotherapy and biologicals. Therefore, the increasing adoption of chemotherapy is ranked among the leading factors for the growth of the Europe automated compounding systems market

Europe has been massively hit by COVID-19 outbreak affecting many of its countries on a large scale. Italy, Germany, Spain, UK and France along with other European countries are continually witnessing rise in number of COVID-19 cases every day. In March 2020, European Medicines Agency has formed an executive committee to deal with impact of COVID-19 on supply chain of medicines. Moreover, the process of shutting down is expected to have severe impact on new product launches and distributions. For instance, Comecer is headquartered in Italy with its factories in Italy and the Netherlands due to the lockdown and severe spread of COVID-19 and complete lockdown in the country will affect the manufacturing process of automated compounding systems.

Rest of Europe Automated Compounding Systems Market Revenue and Forecasts to 2027 (US$Mn)

EUROPEAUTOMATED COMPOUNDING SYSTEMS MARKET SEGMENTATION

ByProduct Type

• Gravimetric Automated Compounding Systems
• Volumetric Automated Compounding Systems

ByEnd Users

• Hospitals
• Chemotherapy Centers
• Others

By Country

• Germany
• France
• UK
• Italy
• Spain

Companies Mentioned

• Braun Melsungen AG
• Comecer
• Grifols, S.A
• NewIcon
• Baxter International Inc.

Europe Automated Compounding Systems Report Scope